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We have developed the GLIF3 Guideline Execution Engine (GLEE) as a tool for executing guidelines encoded in the GLIF3
format. In addition to serving as an interface to the GLIF3 guideline representation model to support the speciﬁed functions, GLEE
provides deﬁned interfaces to electronic medical records (EMRs) and other clinical applications to facilitate its integration with the
clinical information system at a local institution. The execution model of GLEE takes the ‘‘system suggests, user controls’’ ap-
proach. A tracing system is used to record an individual patient’s state when a guideline is applied to that patient. GLEE can also
support an event-driven execution model once it is linked to the clinical event monitor in a local environment. Evaluation has shown
that GLEE can be used eﬀectively for proper execution of guidelines encoded in the GLIF3 format. When using it to execute each
guideline in the evaluation, GLEE’s performance duplicated that of the reference systems implementing the same guideline but
taking diﬀerent approaches. The execution ﬂexibility and generality provided by GLEE, and its integration with a local environ-
ment, need to be further evaluated in clinical settings. Integration of GLEE with a speciﬁc event-monitoring and order-entry en-
vironment is the next step of our work to demonstrate its use for clinical decision support. Potential uses of GLEE also include
quality assurance, guideline development, and medical education.
 2004 Elsevier Inc. All rights reserved.
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In recent years, computer-based guideline models
have been developed to address the need for guideline
representation and execution [1,2]. These models are
used as generic templates to facilitate the translation of
guidelines from their published formats into computer-* Corresponding author. Fax: 1-212-305-3302.
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doi:10.1016/j.jbi.2004.06.002interpretable algorithms [3], to share the clinical
knowledge embedded within guidelines [4], and to assist
the integration of guidelines with the clinical informa-
tion system at a local institution to provide patient-
speciﬁc clinical decision support [5].
Diﬀerent approaches have been used in the previously
developed guideline execution engines, the primary
function of which is to interpret and to execute the
guidelines encoded in speciﬁc representation formats [6–
10]. These approaches usually provided a standard
interpretation of the encoded guidelines, with the
guideline execution engines as the interpreters of speciﬁc
guideline encoding languages. Two important issues that
have not been addressed appropriately by these previous
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such as the handling of the possible disagreement by a
clinician on the guideline recommendations generated
by a computer system [11], and (2) the support for the
maintenance of the guideline execution engine when the
guideline representation model evolves over time.
In 1998, our group, the InterMed Collaboratory (a
research consortium created by informatics groups from
Columbia University, Harvard University, and Stanford
University), published the GuideLine Interchange For-
mat (GLIF), aiming to use it as a standard representa-
tion model for the sharing of guidelines among diﬀerent
institutions [12]. Later, a prototype guideline execution
engine was designed and implemented to integrate with
the clinical information system at a local institution for
the execution of guidelines encoded in an enhanced
format of the second version of GLIF (GLIF2) [10]. In
response to that experience, the limitations of GLIF2,
such as the ad hoc approach to the deﬁnition of patient
data and clinical actions, the lack of a speciﬁcation for
the logical expressions, and the limited set of decision
models, have been addressed, and new requirements for
guideline modeling, such as the representation of a pa-
tient’s clinical state, have been included, resulting in the
third version of GLIF (GLIF3) [13]. In this paper, we
present our approach to the design and implementation
of the GLIF3 Guideline Execution Engine (GLEE) that
tries to balance the requirements of the shareability of
guideline encoding, the ﬂexibility of guideline execution,
and the maintainability of guideline implementation
tool. Although GLEE has not yet been integrated with a
functioning clinical system, we believe that its design,
implementation, and testing as a functioning modular
tool provide useful intermediate lessons for the bio-
medical informatics community.2. Overview of the GLIF3 guideline representation model
To help in understanding the GLEE functions that
we describe in the subsequent sections, we provide here a
brief overview of the GLIF3 guideline representation
model. Detailed speciﬁcation of the GLIF3 guideline
representation model can be found elsewhere [14].
In the GLIF3 model, guidelines are represented as
speciﬁc guideline instances. The process of clinical care is
encoded as the algorithm of a guideline. Within an al-
gorithm, instances of ﬁve types of tasks, which are called
guideline steps, can be encoded and linked together in a
ﬂowchart to specify their scheduling and coordination
during guideline application. Speciﬁcally, action steps are
used to record clinical or computational actions; decision
steps are used to encode decision points; patient state
steps are used to specify a patient’s pathophysiological or
management states in the speciﬁc contexts of a guide-
line’s application; and branch steps and synchronizationsteps are used to schedule and to coordinate concurrent
tasks or tasks with arbitrary execution order. The clinical
care process represented in the GLIF3 model can be
nested using subguidelines, and thus multiple views to the
care process with diﬀerent granularities can be deﬁned.
Clinical data in GLIF3 are encoded as data items. These
data items are then referenced by expressions, which are
used to encode decision criteria and patient state. Clinical
events in GLIF3 are encoded as triggering events, which
are used to activate speciﬁc clinical tasks.
GLIF is a guideline representation model that con-
tinues to evolve. The GLIF3 guideline representation
model used for this research, represented in the
Resource Description Framework (RDF) format [15],
can be found at: http://guidelines.dbmi.columbia.edu/
GLEE/GLIF.rdfs.3. Philosophy of design
GLEE is an important component in InterMed’s
framework of guideline sharing [2]. It is built as mid-
dleware that is intended to be integrated with the clinical
information system at a local institution through deﬁned
interfaces to its electronic medical records (EMRs) and
clinical applications. In addition to clinical decision
support, GLEE aims to be used for quality assurance,
guideline development, and medical education [16].
GLEE is currently implemented using the JAVA pro-
gramming language.
3.1. GLEE and guideline lifecycle
It is InterMed’s vision that the lifecycle of a computer-
interpretable guideline consists of a series of stages: (1)
conceptual modeling, (2) encoding, (3) validation, (4)
dissemination, (5) local adaptation, (6) integration with
an implementation system, and (7) application and re-
vision [2]. In this lifecycle, GLEE is to be used primarily
during the guideline implementation stages (6) and (7).
Speciﬁcally, GLEE provides deﬁned interfaces to the
clinical information system at a local institution with a
goal that guideline implementation integrates seamlessly
with the local environment. Since GLEE can be linked to
EMRs, it is intended to be used to assist in the applica-
tion of guidelines to speciﬁc patients. In addition, as
GLEE can be used as a tool to assist in guideline de-
velopment through iterative reﬁnement, it is related to
the conceptual modeling, encoding, and validation of a
guideline. The stages of a guideline’s lifecycle and
GLEE’s role in these stages are shown in Fig. 1.
3.2. GLEE and the GLIF3 guideline representation model
To share the medical knowledge encoded in a speciﬁc
guideline, the guideline represented in the GLIF3 format
Fig. 1. InterMed’s vision on a guideline’s lifecycle and its relationship to guideline model and tools. GLIF editor is used primarily during the
guideline development stages. It can also be used for local adaptation of guidelines. GLEE is used primarily during the guideline implementation
stages. It can also be used as an assisting tool during the guideline development stages. The whole process is based on the GLIF3 guideline rep-
resentation model.
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a local institution through an ad hoc implementation,
where an institution-speciﬁc computer program is writ-
ten to interpret and to integrate that particular guide-
line. Obviously, a local institution that takes this
approach to guideline implementation needs to invest
extensive resources. Alternatively, implementation of a
guideline that is encoded in the GLIF3 format can be
based on a consistent approach to the interpretation,
integration, and application of the GLIF3 model, which
acts as a template of any GLIF3 guidelines during this
process. This standard approach to the execution of a
guideline is an important requirement for guideline
sharing [17], and GLEE was developed precisely for this
purpose. In this paper, we accordingly describe GLEE
as a modular tool that properly applies the GLIF3
model during guideline execution. As such, it serves as a
reference for implementation of a GLIF3 execution
engine that others can use. GLEE’s integration with
speciﬁc clinical systems is the subject of further work.4. System architecture
Since our goal was to develop GLEE as a tool that
would be taken by a local institution to integrate with its
clinical information system, the system architecture of
GLEE was designed to provide ﬂexibility for such in-
tegration.
4.1. GLEE and host clinical information systems
GLEE provides interfaces intended to support inte-
gration with the host clinical information system at alocal institution. These interfaces are used to link GLEE
to a local EMR at the back-end and associated clinical
applications (e.g., a physician order-entry system) at the
front-end. The communication between GLEE and the
EMR at the back-end will enable GLEE’s access to
various resources in the local environment, such as re-
trieval of patient data and monitoring of clinical events
in case the local institution needs to trigger a guideline
through speciﬁc clinical events. The communication
between GLEE and associated clinical applications at
the front-end is intended to enable smooth integration
of the decision support services provided by GLEE,
such as alerts and reminders, within a clinician’s work-
ﬂow [18]. In other words, GLEE deﬁnes the business
logic of a guideline application, the local EMR will
provide data, and the associated clinical applications
will support the interactions between users and a
guideline implementation system. The overall system
architecture is shown in Fig. 2. As the execution engine
for GLIF3 guidelines, GLEE supports the functions
deﬁned in the GLIF3 model. However, it is important to
note that not all the components in Fig. 2 would be
required for GLEE to work properly. For example, if a
local institution does not have a clinical event monitor
and the guidelines implemented at that institution are
not triggered by clinical events, GLEE can function
properly without the integration with a clinical event
monitor.
4.2. Internal structure of GLEE
Internally, GLEE takes a layered approach to parti-
tioning the functions provided by its components.
GLEE is built as a client-server system to obtain maxi-
Fig. 2. The internal structure of GLEE and its interactions with a local environment. GLEE’s components can be classiﬁed into three conceptual
layers, the GLIF3 model, the core components, and the interfaces to the host environment. The communication between GLEE and the EMR at the
back-end enables GLEE’s access to various resources in the local environment, such as retrieval of patient data, and monitoring of clinical events.
The communication between GLEE and associated clinical applications at the front-end enables smooth integration of the decision support services
provided by GLEE, such as alerts and reminders, within a clinician’s workﬂow. The EMR, GLEE, and associated clinical applications deﬁne the
data, the business logic, and the user interface for a guideline’s application. Multiple GLEE clients can be instantiated simultaneously. The
standalone user interface is used only for development and demonstration purposes.
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addition to the interfaces to a local clinical information
system, GLEE also provides a standalone user interface
to facilitate development, testing, and demonstration.
4.2.1. Three-layer conceptual structure
GLEE’s components can be classiﬁed into three
conceptual layers: (1) the GLIF3 guideline representa-
tion model, (2) the core components of GLEE, and (3)
the interfaces to a host clinical information system. The
GLIF3 guideline representation model speciﬁes a set of
generic functions, such as recommendations for speciﬁc
clinical actions and assistance in medical decision-mak-
ing, which should be supported by any tool executing
guidelines encoded in the GLIF3 format. The core
components of GLEE, as an execution environment for
GLIF3, deﬁne an execution model to realize the generic
functions that are required by the GLIF3 representation
model. The interfaces to a host clinical information
system reﬂect GLEE’s assumptions on the interactions
between GLEE and its host environment during guide-
line execution. The internal structure of GLEE and the
relationships among its three conceptual layers are
shown in Fig. 2.As the interfaces between the GLIF3 guideline rep-
resentation model and the core components of GLEE
are clearly deﬁned, maintenance of GLEE is facilitated
by this component-based approach to its development.
Since GLIF is an evolving guideline representation
model, this approach can facilitate future enhancement
of GLEE when new versions of the GLIF model are
developed and thus additional features of the model
need to be supported by GLEE.
4.2.2. Client-server system
Flexibility in the integration of GLEE with a local
clinical information system and its associated clinical
applications is a primary concern in GLEE’s design.
Since a guideline can be applied to multiple patients at
the same time and a patient can be simultaneously eli-
gible for multiple compatible guidelines at a speciﬁc
moment, eﬃcient processing of these interwoven one-to-
many and many-to-one relationships is important dur-
ing guideline execution. We accordingly chose to build
GLEE as a client-server system, with each GLEE client
corresponding to the application of a guideline to a
particular patient. Speciﬁcally, a GLEE server is devel-
oped (1) to handle the interface with the GLIF3 model
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so as to obtain its correct interpretation, (2) to process
the communication with a local environment at the
back-end (including retrieval of guidelines from a
guideline repository, reading and writing of execution
traces when a guideline is applied to a speciﬁc patient,
accessing of patient data from a clinical data repository,
and monitoring of possible clinical events that are used
to trigger the execution of a guideline), (3) to manage the
clients (including bookkeeping of the guideline and pa-
tient in a speciﬁc GLEE client, and recording the in-
formation for client-server communication), and (4) to
provide computational support for task scheduling, task
execution, and state transition for a speciﬁc client.
Meanwhile, a GLEE client is developed (1) to support
the interactions between a clinical application and a user
when that clinical application uses the services provided
by GLEE (such as recommendations of clinical actions
and assistance with medical decision-making as deﬁned
in GLIF3 guidelines), and (2) to record the execution
state in a speciﬁc round of a guideline’s application to a
patient. The relationship between a GLEE server and its
clients as well as their functions in the overall system
architecture of GLEE are shown in Fig. 2.Fig. 3. A screenshot of the standalone user interface at the client side of GLE
is shown as a ﬂowchart at the upper-right portion of the screen. A list of act
currently highlighted step are shown in the upper-left portion of the screen. T
lower portion of the screen. Maintenance information of the guideline is show
used by developers for testing and demonstration rather than by clinicians f4.2.3. Standalone user interface
Although GLEE’s execution will ultimately be in-
voked by running speciﬁc clinical applications, we have
built a standalone user interface at the client side. As
shown in Fig. 3, this standalone user interface is used to
present to developers and implementers the process
structure of a GLIF3 guideline as well as the active steps
at a speciﬁc moment when that guideline is being applied
to a testing patient. It can also be used to check the
detailed information regarding a guideline step. Users
can interact with GLEE using this client-side standalone
user interface to decide whether to start, continue, or
stop the execution of a speciﬁc guideline step. They can
also ﬁnd the documentation about the guideline, such as
the references to the original published guideline and the
maintenance information about the encoded guideline.
It is important to note that this standalone user interface
is developed for system development, debugging, and
demonstration purposes rather than to be used directly
by clinicians in practice. In this paper, we use the
standalone user interface to illustrate the function of
GLEE. We expect that this standalone user interface,
with appropriate enhancements of its function, can be
adapted in the future for medical education toE during development and testing. The algorithm of a GLIF3 guideline
ive steps, the hierarchy of algorithms, and detailed information on the
he setting of the current client and the execution trace are shown in the
n in the pop-up window. Note that this user interface is intended to be
or patient care.
2 In the standalone user interface, this is reﬂected as the start of a
decision step. We provide detailed description on a guideline step’s
execution state in Section 5.
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line and as a testing tool augmenting the function of a
guideline editor to validate the encoded guidelines. A
guideline’s presentation to a clinician providing patient
care will be very diﬀerent, however, and will generally
require tight integration of GLEE with other clinical
systems such as order-entry or result-reporting.
4.3. System interfaces
In the system architecture of GLEE, guidelines en-
coded in the GLIF3 format are stored in a guideline
repository, from which they can be retrieved by the
GLEE server. The system interface between GLEE and
the guideline repository is deﬁned for this purpose. As
retrieval of a guideline occurs through this deﬁned in-
terface, GLEE does not make any assumption on how
the guidelines are stored in the guideline repository.
However, as GLEE needs to parse a guideline to create
the internal representation of that guideline when it is
retrieved from the guideline repository for the ﬁrst time,
the syntax of the retrieved guideline should be prede-
ﬁned. Currently, the GLIF3 guidelines we have used
were developed using the Protege-2000 knowledge ac-
quisition tool [19] and exported as RDF ﬁles [15].
The system interface between the GLEE server and a
host clinical information system at the back-end is de-
ﬁned for several purposes. First, the GLEE server’s re-
trieval of patient data from the local clinical data
repository is through this system interface. Second, the
GLEE server’s registration of clinical events with the
local clinical event monitor, and the local clinical event
monitor’s notiﬁcation to the GLEE server on triggering
of speciﬁc clinical events, are through this system in-
terface. In addition, this system interface is used for the
retrieval of execution traces, which record the history of
the application of a speciﬁc guideline to a particular
patient, and for sending back to the host system the
trace records that document the recently performed ex-
ecutions. Finally, a messaging function, which is pro-
vided to support the GLEE server’s sending of a generic
message to the host system for speciﬁc types of com-
munication (the semantics can be deﬁned at a local in-
stitution), is also implemented through this system
interface between the GLEE server and the host clinical
information system.
The system interface between the GLEE client and
the clinical applications at the front-end is deﬁned to
facilitate the interactions between a user and GLEE. It is
used (1) to select a particular guideline and a speciﬁc
patient for execution, (2) to provide recommendations
for clinical actions, (3) to assist medical decision-mak-
ing, (4) to verify a patient’s clinical or management
state, (5) to execute a guideline at diﬀerent granularity
levels of its subguidelines, and (6) to support a user’s
subjective decision on guideline execution (i.e., theirdecision on whether to follow the guideline’s advice or
to pursue a diﬀerent course). This system interface is
also used by GLEE’s client-side standalone user inter-
face to support the interactions between a developer
user and GLEE. For example, at a speciﬁc decision
point of a guideline,2 a GLEE client ﬁrst sends the set of
possible options to the user interface so that they can be
presented. Once the decision has been made, the result
of the decision is sent back to the GLEE client. In a
clinical application, such as a physician order-entry
system, if the decision is to select an appropriate medi-
cation for a speciﬁc patient, a GLEE client needs to send
to the order-entry system the set of medications that can
be selected in that context. The order-entry system then
sends back to the GLEE client the speciﬁc medication
that has been ordered.5. Task scheduling and tracing system
As described previously, a discrepancy may arise
between a patient’s expected state as encoded in a spe-
ciﬁc context of a guideline and his or her actual state as
judged by a clinician during guideline application.
GLEE thus allows a user to override a system’s rec-
ommendation during guideline execution. To provide
this ﬂexibility in guideline execution, we developed an
execution model for GLEE to support user-controlled
task scheduling. In addition, we developed a tracing
system for GLEE to record the guideline execution
process. This tracing system, integrated with GLEE’s
guideline execution model, can be used to recover the
execution history of a guideline’s application to a spe-
ciﬁc patient.
5.1. User-controlled task scheduling
The traditional approach to task scheduling during
guideline execution is to determine mechanically the
executable tasks deﬁned by an encoded guideline in a
speciﬁc context when the guideline is applied to a pa-
tient. In this approach, the whole process of task
scheduling is completely controlled by the execution
engine. A major drawback of this approach is that an
encoded guideline generally cannot address every pos-
sible clinical scenario, and thus may lead to discrepan-
cies between what the guideline system suggests and
what the clinicians may correctly determine should be
done for a patient. Several guideline representation
models, including GLIF3, have addressed this issue by
providing representation primitives such as patient sce-
narios or patient states that can be used to record a
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line [14,20,21]. These patient scenarios or patient states
can then be used as entry/exit points to a guideline when
applied to a patient. Although this solution can provide
some level of ﬂexibility in execution, it still depends to a
large extent on the guideline encoders’ enumeration of
all possible entry/exit points for a guideline. This ex-
plains the need to allow a user to override the system’s
recommendation, which is important for the successful
application (and acceptance) of a guideline in a clinical
environment. We therefore decided that GLEE should
provide an extra level of ﬂexibility in guideline execu-
tion, with the user of GLEE as the ﬁnal decision maker
in task scheduling. In other words, at any time during
the execution of a guideline, users can follow the task
schedule suggested by the system, or they can start or
stop the execution of any step based on their own
judgment.
5.2. Execution states and transitions
To distinguish the steps scheduled by GLEE ac-
cording to the encoded guideline from those actually
executed according to a user’s decision, we use four
execution states to represent the status of a guideline
step during execution. These four execution states of a
guideline step include (1) the prepared state, which
means a step is suggested as executable by the execution
engine according to the encoded guideline, (2) the star-
ted state, which means a step has actually been started
by a user, (3) the stopped state, which means a step has
been intentionally stopped by a user before it starts or
completes its execution, and (4) the ﬁnished state, which
means a step has normally completed its execution based
on GLEE’s scheduling. The prepared state and the
started state are jointly called the active state. The ﬁn-
ished state and the stopped state are jointly called the
inactive state. At any time during a guideline’s execu-
tion, the execution states of its guideline steps are kept in
an internal record. These execution states are updated
appropriately during the guideline execution process.
Typically, the GLEE task scheduler suggests execut-
able steps based on the scheduling information encoded
in speciﬁc guideline steps, or, in the case of a new en-
counter when applying a speciﬁc guideline to a partic-
ular patient, based on the trace record of previous
encounters with the guideline by the current patient.
These executable steps are then put into the prepared
states. Users can either conﬁrm GLEE’s suggestion on
the execution schedule, or they can decide to override it
by stopping a prepared step and starting another step
they think to be appropriate. Users can also stop a
started step to avoid unnecessary waiting for completion
of an execution that is no longer relevant. If there is no
manual interference from users, GLEE will decide when
a started step should ﬁnish its execution. Usually, thiswill trigger the execution of other steps that will be put
into the prepared states by the GLEE task scheduler.
We use an example to illustrate the change of a
guideline step’s state during the guideline execution
process. Suppose GLEE has been used in the imple-
mentation of an immunization guideline to provide re-
minders of vaccines due for speciﬁc patients. Patient A
has had two vaccine doses previously, but only the ﬁrst
dose has been recorded in the clinical data repository.
During a visit of patient A, when the immunization
guideline is invoked, GLEE puts the 1 Previous Dose
patient state step, which means the patient had one
vaccine dose previously, into the prepared state ac-
cording to the immunization history data stored in the
clinical data repository. If this recommendation were
conﬁrmed by a clinician, the 1 Previous Dose patient
state step would be put into the started state such that
the system would be able to check the patient’s eligibility
for the 2nd dose of the vaccine. However, if patient A’s
physician ﬁnds from a paper record that patient A has
already had two previous vaccine doses, she will refuse
the recommendation generated by the system. Accord-
ingly, GLEE will put the 1 Previous Dose patient state
step into the stopped state and put the 2 Previous Doses
patient state step, which means the patient has two
vaccine doses previously, into the started state (in a
functioning clinical system this can be implemented
through the documentation or re-entry of the missing
dose) such that the system can check the patient’s eli-
gibility for the 3rd dose of the vaccine. In this way, a
clinician user will be able to correct the inappropriate
recommendations that may be generated by the GLEE
system. The execution states of a guideline step and the
transitions between these states are shown in Fig. 4.
Providing execution ﬂexibility by introducing users’
decisions regarding task scheduling does not mean that
users have to make this decision in each and every step
of guideline execution. By appropriate conﬁguration,
the system’s automatic execution (for those tasks with
clearly deﬁned and veriﬁed logic) and users’ subjective
decisions (for those tasks that need clinicians’ judg-
ments) can be combined to serve special needs when
implementing a particular guideline. For example, we
currently provide a batch execution mode to support the
application of a speciﬁc guideline to multiple patients.
When running in this mode, GLEE automatically ac-
cepts all executable steps recommended by its task-
scheduler, and selects a prepared step to execute each
time a user selection is needed. This batch execution
mode was used in the evaluation of GLEE (described in
Section 10).
5.3. Tracing system
Keeping the trace of execution for a speciﬁc guideline
when it is applied to a particular patient is an important
Fig. 4. The execution state of a guideline step and the transitions between these execution states. GLEE suggests an executable step and puts it into
the prepared state. A user of GLEE decides whether to follow GLEE’s suggestion or to deny it by stopping the suggested step and initiating the start
of another step. A user can also stop a started step that is no longer relevant. If there is no manual interference from users, GLEE decides when a
started step should ﬁnish its execution.
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line execution trace of a patient to record (1) the acti-
vation of a step, (2) the start of a step, (3) the ﬁnish of a
step, (4) the stop of a step, and (5) the chaining of steps.
When implemented as an integrated component of an
EMR environment, these patient-speciﬁc traces would be
stored internal to the GLEE tool as described below.
The execution trace for a speciﬁc patient can be used
as a hint for task scheduling in future encounters with
the patient when the same guideline is re-applied. Spe-
ciﬁcally, if the trace has shown that the execution of
speciﬁc guideline steps had not been ﬁnished in previous
applications of the guideline to the current patient, those
unﬁnished guideline steps will be recommended by
GLEE as the potential starting points when the same
guideline is re-applied to that patient. This feature of
GLEE is provided for implementation of guidelines on
chronic disease management, where the application of a
guideline to a particular patient usually involves multi-
ple encounters. With GLEE’s capability to parse the
execution trace that records previous encounters, ap-
plication of a guideline to a speciﬁc patient can start
from a particular point in the guideline that corresponds
to the patient’s current management state instead of
from the beginning of the guideline in each encounter.
The execution trace can provide a complete record of
a guideline’s execution for quality assurance purposes to
determine whether the care provided to a speciﬁc patient
is in compliance with guideline recommendations. Ide-
ally, the trace record used for such purposes would
simply be extracted from a patient’s medical record. In
fact, some of the execution history that is recorded in the
trace (e.g., the start of an action step that corresponds to
a speciﬁc type of clinical intervention, such as the pre-
scription of a medicine) can be found in a typical medical
record. However, many other elements in GLEE’s trace
records may not have been documented there but are
required for the proper execution of a guideline. For thisreason, we chose to keep an independent trace record
system that could be used by the GLEE server, as shown
in Fig. 2. Currently, these trace records are implemented
as XML [22] ﬁles that are stored at the server side of
GLEE. The document type deﬁnition (DTD) of the
execution trace XML ﬁle can be found at: http://guide-
lines.dbmi.columbia.edu/GLEE/GLEETraceDTD.html.6. Event model
An event-driven execution model is an intrinsic part
of many clinical decision support systems [23]. GLIF3
supports such an execution model by deﬁning triggering
events for a speciﬁc guideline step.
The support for the event-driven guideline execution
mode depends on the availability of the clinical event
monitor at a local institution. If a local institution would
like to support the guideline execution mode that is
driven by clinical events, such as the newly arrived lab
results or the entry of physician orders, it needs to
provide a clinical event monitor with which the GLEE
server connects. During guideline execution, when a step
with a triggering event is started, GLEE ﬁrst registers
that event with the clinical event monitor at the local
site. It then waits for the occurrence of the registered
event to trigger its execution. Once a clinical event oc-
curs, the clinical event monitor at the local institution
sends a message to the GLEE server to notify the trig-
gering of the event. The guideline step that is waiting for
the event is then triggered to start its execution.7. Task execution
Execution of the speciﬁc types of tasks deﬁned in a
guideline representation model is one of the most im-
portant functions of a guideline execution engine. For
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elements in GLIF3 that are used to encode the speciﬁc
types of clinical tasks as well as those that are used to
support the scheduling of the clinical tasks.
7.1. Execution of clinical tasks
In the GLIF3 guideline representation model, the
elements that are used to represent the diﬀerent types of
clinical tasks include action step, decision step, and pa-
tient state step.
Handling of an action step depends on the type of
task deﬁned in that step. Speciﬁcally, GLEE sends a
message to notify the local clinical information system if
the task deﬁned in the action step is a medically oriented
action; GLEE updates its internal data assignment record
if the task is an assignment action; GLEE communicates
with the clinical data repository at the local institution
to retrieve speciﬁc patient data and updates the internal
data assignment record if the task is a get data action;
and ﬁnally, GLEE starts the execution of a subguideline
if the task is a subguideline action. Once it has ﬁnished
the processing of the tasks, GLEE obtains the sub-
sequent step as deﬁned in the current action step. This
subsequent step is then scheduled to be executed.
The decision step in the GLIF3 model can be classi-
ﬁed into case step, which represents a decision-making
process that can be implemented by GLEE automati-
cally, and choice step, which represents a decision-
making process that needs inputs from a user. GLEE
handles the case step and choice step diﬀerently. For a
case step, GLEE scans its options and evaluates the
criterion of the case condition in each of the options until
the criterion of an option can be satisﬁed, leading to the
selection of that option as the decision result. For a
choice step, GLEE presents the options of the step to a
user at the client side and waits for the user’s decision on
the selection of the options. After an option is selected in
the decision-making process, the subsequent step cor-
responding to that option is obtained. GLEE then
schedules this subsequent step to be executable and
updates the relevant trace record.
The patient state step in the GLIF3 model is used as a
label to specify a patient’s clinical or management state
in a particular context of a guideline’s application. The
patient state description of a patient state step is a crite-
rion to deﬁne a patient’s status as represented by the step
(i.e., the eligibility/applicability criteria). Ideally, this
information should be compared to a patient’s actual
state during guideline application to automatically select
or narrow the search for the possible states of a patient.
Currently, this information is simply presented to a user
at the client side; the user will make the ﬁnal decision on
whether the observed patient data match with the crite-
rion deﬁned in the patient state step. If so, the patient
state is validated and the subsequent step is scheduled.7.2. Execution of scheduling tasks
In the GLIF3 guideline representation model, the
elements that are used to represent the diﬀerent types of
scheduling tasks include branch step, synchronization
step, and subguideline. These tasks constitute GLEE’s
computational support for workﬂow management so
that coordination of speciﬁc tasks can be implemented
during guideline application.
The branch step in the GLIF3 model is used to rep-
resent a diverging point in a guideline’s algorithm so
that concurrent tasks and tasks with arbitrary execution
order can be represented. The branch step itself does not
have any internal tasks that need to be performed. Its
uniqueness is its chaining with the subsequent steps. The
major diﬀerence between a branch step and other types
of steps is that a branch step has multiple subsequent
steps, while others have only one. Consequently, after
the execution of a branch step, GLEE needs to schedule
all the subsequent steps by putting them into the pre-
pared state so that they will become executable.
The synchronization step in the GLIF3 model is used
to represent a converging point in a guideline’s algorithm
so that multiple tasks can be coordinated during a
guideline’s application. When a synchronization step is
executed, its continuation criterion is evaluated. During
this evaluation, GLEE checks the execution history as
recorded in the execution traces. If the continuation cri-
terion is not satisﬁed, the synchronization step will con-
tinue towait until the completion of other steps eventually
leads to the fulﬁllment of the continuation criterion.
In the GLIF3 model, subguidelines are used to pro-
vide diﬀerent views to the clinical care process. When a
step with a subguideline deﬁned is started, the user of
GLEE can select to go to the lower level of the guideline
hierarchy to execute the subguideline, or to skip the
subguideline to keep the execution at the current level of
the guideline hierarchy if the goal of the subguideline
has already been achieved. Once a user decides to exe-
cute the subguideline, the ﬁrst step of the subguideline is
scheduled to be executable, leading to the initialization
of that subguideline’s execution. During the whole exe-
cution process of the subguideline, the step of the upper
level guideline within which the subguideline is deﬁned
will remain in the started state. After the execution of an
ending step, beyond which no subsequent step is deﬁned
in the subguideline, execution of the subguideline is
ﬁnished, leading to the return of the control of the task
scheduling back to the upper level (invoking) guideline.8. Patient data retrieval, clinical event registration, and
clinical action notiﬁcation
Access to patient data is a critical task in guideline
execution [24]. For guidelines to be shared across
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and a generic patient data model are two prerequisites.
This standard data encoding system plus a generic pa-
tient data model will enable references to patient data in
an encoded guideline such as in a speciﬁcation of deci-
sion criteria without the need to know the implemen-
tation details. At a local institution, the standard
deﬁnition of patient data are then mapped to the im-
plementation-speciﬁc data schema and access methods
of the local EMR. In recent years, several controlled
medical terminologies, such as SNOMED-CT [25] and
LOINC [26], have been developed as standards for pa-
tient data encoding. However, there is as yet little con-
sensus on a common patient data model in the
biomedical informatics research community. For this
reason, we do not assume any speciﬁc standard on the
use of controlled medical terminologies and patient data
models. Instead, guideline encoders can select their own
controlled medical terminology and patient data model
when encoding patient data [27]. During guideline exe-
cution, patient data access is through a standard inter-
face to the clinical data repository at a local institution,
with the identiﬁcation of the terminology, the concept in
the terminology that is used to represent the data, the
patient data model, and the speciﬁc data-model class as
the parameters in the communication. Using these pa-
rameters and the mapping between this deﬁnition of
patient data and the schema of the clinical data reposi-
tory at a local institution, the patient data required by
GLEE during guideline execution can then be retrieved
from the local clinical data repository. This approach is
compatible with the recent research on the development
of a virtual medical record by building a standard patient
data model on the basis of HL7’s Reference Information
Model (RIM), which is then mapped to the database
schema of a local institution [28]. It is important to note
that this way to use a controlled medical terminology
and patient data model by GLEE has not yet solved the
curly braces problem,3 which refers to the hindrance of
medical knowledge sharing caused by incompatible ap-
proaches to patient data representation [29]. However,
the current approach can at least promote the stan-
dardization of patient data representation and thus
move toward the long-term goal to share completely the
medical knowledge that is embedded within guidelines.
Registration of clinical events and notiﬁcation of
clinical actions are implemented in GLEE using a sim-
ilar approach, with the identiﬁcation of a controlled
terminology and the concept in that terminology cor-3 Unless the controlled medical terminology and the patient data
model used by GLEE are universally accepted, consistent interpreta-
tion of the encoded patient data still needs the mapping of the
controlled medical terminologies and the patient data models at
diﬀerent local institutions. This becomes a local implementation task
when integrating GLEE with a clinical information system.responding to the event or the clinical action as the
parameters in the communication between GLEE and
the local environment.9. Expression language and scheduling constraint speci-
ﬁcation language
The expression language is used in GLIF3 to encode
decision criteria and patient states. Because an expres-
sion language is closely related to the data model that
presupposes how the variables in an expression can be
referenced, the standardization of an expression lan-
guage partially relies on the standardization of patient
data model. Due to the lack of a standard patient data
model, standardization of the expression language is
currently under development. Thus, GLIF3 does not
assume a speciﬁc expression language. Instead, GLIF3
supports diﬀerent expression languages, the appropri-
ateness of which can be decided by guideline encoders.
In the current implementation of GLEE, we use the
Guideline Expression Language (GEL) [30,31], which is
based on an extension of the logic expression used in the
Arden Syntax, to encode decision criteria and patient
state. The Backus Naur Form (BNF) notation for the
syntax of the GEL language can be found at: http://
guidelines.dbmi.columbia.edu/GLEE/GEL-BNF.html.
It is important to note that the GEL parser is imple-
mented as a separate package in GLEE, and thus it can
be replaced by or complemented with parsers for other
expression languages.4 Again, this will facilitate the fu-
ture maintenance of GLEE to support a standard ex-
pression language for clinical decision support.
The scheduling constraint speciﬁcation language is
used in GLIF3 to encode the continuation criterion of a
synchronization step. In this language, the names of
particular guideline steps are used as identiﬁers in the
continuation criterion to represent the requirement on
the completion of a synchronization step. The BNF
notation for the syntax of the scheduling constraint
speciﬁcation language can be found at: http://guide
lines.dbmi.columbia.edu/GLEE/SchedulingLanguage
BNF.html.10. Technical evaluation
We performed a study to evaluate the technical ef-
fectiveness of GLEE in terms of its functionality to ex-
ecute guidelines encoded in the GLIF3 format. This
study focused on the evaluation of GLEE’s capability to4 The GEL language is not object-oriented. As the virtual medical
record will likely be an object-oriented data model, we are working on
the development of an object-oriented expression language, GELLO
[32].
5 Here, sensitivity ¼ (total number of cases that were both
detected by a computer-based guideline implementation system and
judged by physicians as to have a vaccine due)/(total number of cases
that were judged by physicians as to have a vaccine due), and
speciﬁcity ¼ (total number of cases that were both detected by a
computer-based guideline implementation system and judged by
physicians as to have no vaccine due)/(total number of cases that
were judged by physicians as to have no vaccine due).
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Although real clinical data were used in the evaluation,
this study did not aim to examine the use of GLEE to
implement GLIF3 guidelines in clinical setting. The
latter requires integration of GLEE with the clinical
information system at a local institution to provide
clinical decision support at the point of care, which
constitutes one aspect of our future work.
We selected two guidelines as the subject guidelines in
the evaluation: (1) the DTP series of the childhood im-
munization guidelines published by the CDC [33], which
recommends the DTP vaccines due for an eligible child,
and (2) the cough guideline published by the US Army
[34], which recommends the possible diagnoses for pa-
tients with cough. These two guidelines were selected
because their encoding require all the elements in the
GLIF3 model. Thus, these two guidelines taken together
can be used to examine whether GLEE can correctly
handle each representation element in the GLIF3 model.
For the DTP immunization guideline, we reused 2007
patient cases that had been used previously in a clinical
trial of the EzVac system [35], a computer-based im-
munization registry that implemented the same DTP
immunization guideline but was not based on the
GLIF3 model. For the cough guideline, domain experts
manually created 20 typical patient cases, starting with a
speciﬁc disease that may lead to cough and listing a set
of typical symptoms, signs, and lab test results associ-
ated with that disease.
To evaluate its technical eﬀectiveness, we used GLEE
to execute the patient cases for each of the two subject
guidelines. The appropriateness of the ﬁnal recommen-
dations generated by GLEE was used as the outcome
variable. For the DTP immunization guideline, the
recommendation outcome variable was the vaccines due
for a child. For the cough guideline, the recommenda-
tion outcome variable was the possible diagnoses of
cough. We used physicians’ judgments as the gold
standard in the evaluation. For the DTP immunization
guideline, we compared the results generated by GLEE
with those generated by the EzVac system, using the
latter as an external reference to measure the perfor-
mance of GLEE. For the cough guideline, we used the
performance of GLEE on the ﬁrst 10 cases as a reference
to measure its performance on the last 10 cases. Since
the ﬁrst 10 cases were used to tune the encoding of the
decision criteria of the cough guideline, GLEE’s per-
formance on these cases was used as the baseline data.
To avoid possible bias due to the inconsistent under-
standing of the same DTP immunization guideline by
diﬀerent encoders, the author who was the primary de-
veloper of the DTP immunization guideline in the Ez-
Vac system (DW) encoded the same guideline in the
GLIF3 format. To avoid possible bias due to the dif-
ferent styles of encoding, another author (MP) encoded
the cough guideline in the GLIF3 format.For the DTP immunization guideline, GLEE and
EzVac generated consistent results for 1978 out of the
2007 cases (98.56%); while in the remaining 29 cases
(1.44%), their execution results were inconsistent. To
evaluate the appropriateness of the ﬁnal recommenda-
tions, we gave all the 29 inconsistent cases and 20 cases
that were randomly selected from the 1978 consistent
cases to two attending physicians with suﬃcient famil-
iarity with CDC’s DTP childhood immunization
guideline for the ﬁrst round of the review. In this round,
the two physician judges did not know the recommen-
dations generated by GLEE and EzVac. Instead, they
made their own judgments on the possible vaccines due
for a speciﬁc patient case. These decisions were based
solely on the case description of a patient’s immuniza-
tion history and other necessary information. The sen-
sitivity and the speciﬁcity of GLEE in this round were
99.71% and 67.65%, respectively; and the sensitivity and
the speciﬁcity of the EzVac system in this round were
99.43% and 67.48%, respectively.5 Within the 49 cases
that were reviewed by the two physicians in the ﬁrst
round, there were ﬁve cases on which the judgments by
the physicians were diﬀerent from the results generated
by either GLEE or EzVac. As the EzVac system had
already been validated in the previous clinical trial, the
chance of an incorrect physician judgment is high when
that judgment diﬀers from either of the results generated
by GLEE and EzVac. To improve the reliability of the
physicians’ judgments without excessive extra invest-
ment in time and human resources, only the above ﬁve
cases were sent back to the physicians for a second re-
view. This time the results generated by GLEE and
EzVac were available to the physician judges. The sen-
sitivity and the speciﬁcity of GLEE in the second round
of the review were 99.80% and 80.74%, respectively; and
the sensitivity and the speciﬁcity of the EzVac system in
the second round of the review were 99.53% and 80.55%,
respectively.
For the cough guideline, GLEE was used to execute
20 patient cases. For each case, it generated a set of
possible diagnoses. To evaluate the appropriateness of
these diagnoses, we gave all the 20 cases and their cor-
responding diagnosis sets to two attending physicians
(diﬀerent from the previous two physicians in the eval-
uation of the DTP immunization guideline) with suﬃ-
cient familiarity with the cough guideline for a review.
The percentage of the correct (the diagnosis is the ori-
ginal diagnosis from which the case was created), ac-
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which the case was created, but a reasonable diagnosis
that may lead to the manifestation of the symptoms,
signs, and lab test results shown in the case description),
and wrong (the diagnosis is not the original diagnosis
from which the case was created, and not a reasonable
diagnosis that may lead to the manifestation of the
symptoms, signs, and lab test results shown in the case
description) diagnoses for case 1 to case 10 were 39%,
47%, and 14%, respectively; and the percentage of the
correct, acceptable, and wrong diagnoses for case 11 to
case 20 were 47%, 45%, and 8%, respectively. For all the
20 cases, the diagnosis set generated for a speciﬁc case
contained the original diagnosis from which that case
was created (for case 1 to case 10, this was realized
through the tuning of the encoding; for case 11 to case
20, this was a natural result generated by GLEE).
The execution results of both guidelines have shown
that the performance of GLEE in terms of the appro-
priateness of the ﬁnal recommendations has reached the
level of the reference systems against which it was being
compared. Speciﬁcally, in the execution of the DTP
immunization guideline, the sensitivity and the speciﬁc-
ity of GLEE were at the same level of the EzVac system;
in the execution of the cough guideline, the accuracy of
GLEE when it was used to execute the last 10 cases was
a little better than that when it was used to execute the
ﬁrst 10 cases. Analyses of the cases with clinically invalid
results found that the problems were due to (1) errors in
data preprocessing of the immunization guideline, (2)
imperfect encoding of the cough guideline (due to the
limitation of resources, when using the ﬁrst 10 cases to
tune the encoding of the cough guideline, we stopped the
tuning for a case after verifying that the diagnosis from
which the case was originally created had been included
in the diagnosis set of that case generated by GLEE), (3)
incorrect assumptions on the number of days in a month
made by the GEL language (a problem that was inher-
ited from the Arden Syntax), and (4) physicians’ ﬂexible
interpretation of the decision criteria (e.g., while the
DTP guideline recommended that the interval between
dose 1 and dose 2 should be at least 6 weeks, one of the
physician judge thought it was OK for 41 days). Only (3)
was a problem of the GLEE system itself.11. Discussion
GLEE is intended to be used as a modular interpreter
of GLIF3 guidelines. Our results have shown that it can
be used eﬀectively for this purpose except on rare oc-
casions due to a minor problem in the expression lan-
guage used in the current implementation. However,
even if an execution engine can correctly interpret
guidelines, the recommendations it generates may still
not be accepted by a clinician. The results of our eval-uation have shown that poor data quality, imperfect
encoding of a guideline, and clinicians’ ﬂexible inter-
pretation of guideline may all lead to the unacceptability
of a guideline’s advice, even when otherwise the guide-
line would have been correctly executed. Thus, we be-
lieve the execution ﬂexibility provided by GLEE is
especially important to address this issue when imple-
menting guidelines in clinical settings. With such
ﬂexibility, even if clinicians reject an irrelevant or inap-
propriate suggestion when applying a guideline to a
patient, they do not have to abandon the application of
the entire guideline. Instead, they can always come back
to the guideline and start a relevant step at a later time
when they think it is appropriate. In this way, GLEE
may overcome the limitations of previous approaches
that depend on (1) a guideline encoder’s enumeration of
all possible clinical states of a patient during the appli-
cation of a speciﬁc guideline, (2) high quality of clinical
data, and (3) clinicians’ stringent interpretation of the
guideline. Comparing to the approach used by GUIDE
that can only handle a limited set of exceptions [36], the
execution ﬂow of GLEE can be arbitrarily changed by
users as they judge as appropriate. Further evaluation of
GLEE on its use for this purpose will be necessary after
it has been integrated with the clinical information sys-
tem at one or more local institutions to provide clinical
decision support in practice.
Integration of decision support within clinicians’
workﬂow is a critical factor for its success [18]. Thus, we
believe a standard interface between a guideline execu-
tion system and associated clinical applications is im-
portant for guideline implementation in clinical settings.
The interface to the clinical applications provided by the
GLEE system is intended to facilitate this integration
and to promote the use of guidelines in clinical practice.
Nevertheless, we do not exclude the possibility that a
local system can provide its own methods of commu-
nication and presentation for alerts and reminders.
GLEE thus provides the messaging function at the back-
end so that it can be used in this case as an alternative to
facilitate the communication and integration. Further
evaluation on this capability of GLEE needs to be per-
formed in clinical settings.
Finally, the interface between the guideline repre-
sentation model and other parts of the execution engine
facilitates the maintenance of the execution system itself,
including the evolution of the representation model and
the generalization of the execution model. Further dis-
cussion on this topic is beyond the scope of this paper
but can be found elsewhere [37].
Due to the restriction of available resources, the
evaluation of GLEE was performed in a lab setting on a
limited scale. In a production environment, additional
eﬀorts should be placed into the guideline encoding
process to maximize its correctness. In addition,
when future evaluations on GLEE’s capabilities are
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trained to enhance the reliability of their judgments.
We are now working on the integration of GLEE
with the clinical information system at New York-
Presbyterian Hospital. Once this integration is com-
pleted, we will perform further studies on GLEE’s use in
clinical settings, including the impact of its execution
ﬂexibility on clinicians’ use of guidelines.12. Summary
We have developed the GLEE system to balance the
requirements of guideline sharing, execution ﬂexibility,
and system maintenance. The technical evaluation of
GLEE has shown that it can be used eﬀectively for ex-
ecution of guidelines encoded in the GLIF3 format.
GLEE’s use in clinical settings needs to be evaluated in
the future. We understand, however, that wide accep-
tance of a guideline system in clinical practice depends
on many other factors, such as the development of a
widely-accepted standard patient-data model and the in-
depth understanding of local adaptation of guidelines.
These issues are not addressed in our current work but
help to deﬁne the challenges for the future. On the other
hand, we believe that the modular design of GLEE will
facilitate adoption and use of such standards for
guideline-based decision support when a consensus de-
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